CMPX ▲ +1.5% - Compass Therapeutics, Inc.
$CMPX - Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 (PD-1 x VEGF-A Bispecific Antibody) at the SITC 2026 Annual Meeting
06-NOV-2026 09:00 AM ET
Share this post
More filings for $CMPX
CMPX ▲ +1.3% - Compass Therapeutics, Inc.Nov 2, 2026CMPX ▼ -3.8% - Compass Therapeutics, Inc.Oct 24, 2026CMPX ▲ +1.6% - Compass Therapeutics, Inc.Sep 23, 2026CMPX ▼ -13.2% - Compass Therapeutics, Inc.Sep 22, 2026CMPX - Compass Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026CMPX - Compass Therapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026
View full $CMPX filing history →💬 Comments
Loading comments…
Leave a comment